Biodesix IncNASDAQ:BDSX
- LAST PRICE1.4400
- TODAY'S CHANGE (%)0.0150 (1.0526%)
- Bid / Lots1.4000/ 40
- Ask / Lots1.4700/ 10
- Open / Previous Close1.4400 / 1.4250
- Day Range
- 52 Week Range
- Volume173,213
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDSX |
|---|---|---|
| 09:32 ET | 1285 | 1.46 |
| 09:37 ET | 705 | 1.46 |
| 09:39 ET | 100 | 1.45 |
| 09:42 ET | 100 | 1.48 |
| 09:44 ET | 200 | 1.48 |
| 09:48 ET | 2075 | 1.465 |
| 09:50 ET | 280 | 1.4568 |
| 09:51 ET | 450 | 1.465 |
| 09:53 ET | 600 | 1.47 |
| 09:55 ET | 702 | 1.46 |
| 10:00 ET | 100 | 1.46 |
| 10:02 ET | 800 | 1.46 |
| 10:06 ET | 300 | 1.46 |
| 10:09 ET | 500 | 1.46 |
| 10:11 ET | 600 | 1.46 |
| 10:13 ET | 500 | 1.46 |
| 10:15 ET | 1300 | 1.47 |
| 10:18 ET | 200 | 1.47 |
| 10:20 ET | 100 | 1.46 |
| 10:22 ET | 1000 | 1.455 |
| 10:24 ET | 5433 | 1.455 |
| 10:26 ET | 200 | 1.445 |
| 10:27 ET | 300 | 1.445 |
| 10:29 ET | 300 | 1.445 |
| 10:31 ET | 810 | 1.445 |
| 10:33 ET | 610 | 1.445 |
| 10:36 ET | 541 | 1.445 |
| 10:38 ET | 300 | 1.45 |
| 10:42 ET | 100 | 1.445 |
| 10:44 ET | 100 | 1.445 |
| 10:45 ET | 100 | 1.445 |
| 10:47 ET | 584 | 1.45 |
| 10:49 ET | 528 | 1.45 |
| 10:51 ET | 300 | 1.46 |
| 10:56 ET | 350 | 1.45 |
| 11:03 ET | 3638 | 1.455 |
| 11:05 ET | 2022 | 1.455 |
| 11:07 ET | 5913 | 1.47 |
| 11:09 ET | 2885 | 1.475 |
| 11:12 ET | 3620 | 1.475 |
| 11:14 ET | 376 | 1.475 |
| 11:16 ET | 300 | 1.48 |
| 11:18 ET | 300 | 1.48 |
| 11:20 ET | 400 | 1.48 |
| 11:21 ET | 600 | 1.475 |
| 11:23 ET | 300 | 1.48 |
| 11:25 ET | 400 | 1.48 |
| 11:27 ET | 100 | 1.48 |
| 11:30 ET | 300 | 1.48 |
| 11:32 ET | 600 | 1.475 |
| 11:34 ET | 200 | 1.475 |
| 11:36 ET | 200 | 1.475 |
| 11:39 ET | 300 | 1.48 |
| 11:41 ET | 2373 | 1.475 |
| 11:43 ET | 4580 | 1.47 |
| 11:48 ET | 3703 | 1.465 |
| 11:52 ET | 611 | 1.46 |
| 11:54 ET | 400 | 1.45 |
| 11:56 ET | 100 | 1.46 |
| 11:57 ET | 100 | 1.45 |
| 12:01 ET | 400 | 1.45 |
| 12:03 ET | 200 | 1.45 |
| 12:06 ET | 300 | 1.46 |
| 12:08 ET | 300 | 1.46 |
| 12:10 ET | 500 | 1.46 |
| 12:12 ET | 200 | 1.46 |
| 12:14 ET | 500 | 1.46 |
| 12:17 ET | 200 | 1.46 |
| 12:19 ET | 100 | 1.47 |
| 12:21 ET | 776 | 1.47 |
| 12:26 ET | 200 | 1.47 |
| 12:28 ET | 5836 | 1.465 |
| 12:30 ET | 2300 | 1.455 |
| 12:32 ET | 100 | 1.455 |
| 12:33 ET | 100 | 1.45 |
| 12:35 ET | 808 | 1.46 |
| 12:37 ET | 1892 | 1.455 |
| 12:39 ET | 400 | 1.455 |
| 12:42 ET | 300 | 1.455 |
| 12:44 ET | 400 | 1.455 |
| 12:46 ET | 4586 | 1.455 |
| 12:48 ET | 600 | 1.46 |
| 12:50 ET | 6124 | 1.455 |
| 12:51 ET | 1400 | 1.46 |
| 12:53 ET | 2400 | 1.45 |
| 12:55 ET | 3700 | 1.455 |
| 12:57 ET | 5997 | 1.455 |
| 01:00 ET | 62889 | 1.44 |
Nov 1, 2024
Biodesix Announces Third Quarter 2024 Results and Highlights, from 6:00AM ET on Friday Nov 01, 2024 by Dow Jones
6:00AM ET on Friday Nov 01, 2024 by Dow JonesPress Release: Biodesix Announces Third Quarter 2024 Results and Highlights, from 6:00AM ET on Friday Nov 01, 2024 by Dow Jones
6:00AM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biodesix Inc | 207.3M | -3.7x | --- |
Longduoduo Co Ltd | 162.6M | 140.3x | --- |
Joint Corp | 172.3M | -10.2x | --- |
Nutex Health Inc | 200.7M | -4.2x | --- |
Zomedica Corp | 125.8M | -2.0x | --- |
Cardiff Lexington Corp | 97.7M | 0.8x | --- |
Company Information
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung Nodule Risk Assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the appropriate course of action. The blood based IQLung strategy for lung cancer patients integrates the GeneStrat targeted ddPCR test, the GeneStrat NGS test and the VeriStrat test to support treatment decisions across all stages of lung cancer. Biodesix also leverages the advanced Diagnostic Cortex artificial intelligence (AI) platform, to collaborate with biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease.
Contact Information
- Headquarters
- 919 West Dillon RoadLOUISVILLE, CO, United States 80027
- Phone
- 303-417-0500
- Fax
- 303-417-9700
Executives
- Independent Chairman of the Board
- John Patience
- President, Chief Executive Officer, Director
- Scott Hutton
- Chief Financial Officer, Treasurer, Secretary
- Robin Cowie
- Chief Commercial Officer
- Kieran O'Kane
- Independent Director
- Jean Franchi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $207.3M |
|---|---|
Revenue (TTM) | $65.6M |
Shares Outstanding | 145.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-0.39 |
Book Value | $0.05 |
P/E Ratio | -3.7x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -53.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
